Table 1 The clinical features of TCGA breast cancer patients.
From: Assessing the prognostic value of stemness-related genes in breast cancer patients
Clinical features | ||
|---|---|---|
Age (years) | Media | 58 |
Rage | 26–89 | |
Numbers of patients (n = 1066) | Numbers of patients (%) | |
Gender | Female | 1055 (98.97) |
Male | 11 (1.03) | |
T stage | T1 | 280 (26.27) |
T2 | 617 (57.88) | |
T3 | 131 (12.29) | |
T4 | 36 (3.38) | |
Unknown | 2 (0.18) | |
N stage | 0 | 501 (47.00) |
1 | 358 (33.58) | |
2 | 118 (11.69) | |
3 | 74 (6.94) | |
Unknown | 15 (0.79) | |
M stage | 0 | 888 (83.80) |
1 | 19 (1.78) | |
Unknown | 159 (14.42) | |
AJCC stage | I | 183 (17.17) |
II | 602 (56.47) | |
III | 240 (22.51) | |
IV | 19 (1.78) | |
Unknown | 20 (2.07) | |
HER-2 status | Positive | 156 (14.63) |
Negative | 560 (52.53) | |
Unknown | 350 (32.84) | |
Estrogen receptor status | Positive | 787 (73.83) |
Negative | 233 (21.86) | |
Unknown | 46 (4.31) | |
